Safety and Efficacy of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Wild-type RAS and BRAF mCRC

NCT03405272 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

BIOLOGICAL: Recombinant Anti-EGFR Monoclonal Antibody（SCT200）

Sponsor

Sinocelltech Ltd.

Collaborators

[object Object]